[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL
Clinical trial NCT01408303 · COMPLETED
Trial details
- NCT number
- NCT01408303
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-06-01
- Enrollment
- 646
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.